Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($0.89), $0.23 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $10.79 million versus the consensus estimate of $20.94 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.